Aslan Pharmaceuticals Ltd (6497)

5.66
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    5.66/5.67
  • Day's Range:
    5.43 - 5.68

6497 Overview

Prev. Close
5.66
Day's Range
5.43-5.68
Revenue
-
Open
5.43
52 wk Range
4.16-9.8
EPS
-7.49
Volume
0
Market Cap
1.08B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,872
P/E Ratio
-
Beta
-
1-Year Change
18.91%
Shares Outstanding
189,955,000
Next Earnings Date
08 Aug 2021
What is your sentiment on Aslan Pharmaceuticals Ltd?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary

Aslan Pharmaceuticals Ltd Company Profile

Aslan Pharmaceuticals Ltd Company Profile

Employees
0
Market
Taiwan

ASLAN Pharmaceuticals Limited (ASLAN) is a clinical-stage immunology and oncology-focused biopharmaceutical company. ASLAN has a clinical portfolio comprised of a first in class monoclonal therapy, ASLAN004, that is being developed in atopic dermatitis and other immunology indications, and a small molecule inhibitor targeting oncology.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.